Subject(s)
Carrier State/microbiology , Cross Infection/prevention & control , Infection Control/methods , Methicillin Resistance , Staphylococcal Infections/diagnosis , Staphylococcus aureus/isolation & purification , Axilla/microbiology , Groin/microbiology , Humans , Nose/microbiology , Perineum/microbiology , Pharynx/microbiology , Staphylococcus aureus/drug effectsSubject(s)
Bone Marrow Transplantation , Parainfluenza Virus 3, Human/pathogenicity , Parainfluenza Virus 4, Human/pathogenicity , Respiratory Tract Infections/virology , Respirovirus Infections/virology , Rubulavirus Infections/virology , Antiviral Agents/therapeutic use , Child , Cross Infection/transmission , Diagnosis, Differential , Humans , Immunocompromised Host , Parainfluenza Virus 4, Human/isolation & purification , Respiratory Tract Infections/drug therapy , Respirovirus Infections/diagnosis , Respirovirus Infections/drug therapy , Respirovirus Infections/transmission , Reverse Transcriptase Polymerase Chain Reaction , Ribavirin/therapeutic use , Rubulavirus Infections/diagnosis , Rubulavirus Infections/drug therapy , Rubulavirus Infections/transmission , VirulenceABSTRACT
A patient with severe burns who was colonized by multiresistant Acinetobacter baumannii was cared for in contact isolation by staff intensively trained on hospital hygiene. Of the 1,907 postexposure cultures from the staff and 425 environmental samples, only 0.7% and 4%, respectively, yielded this microorganism. These data show that strict hygienic measures may limit staff colonization and contamination of the environment byA baumannii.
Subject(s)
Acinetobacter Infections/etiology , Acinetobacter Infections/transmission , Acinetobacter/isolation & purification , Burns/complications , Infectious Disease Transmission, Patient-to-Professional/prevention & control , Personnel, Hospital/statistics & numerical data , Acinetobacter Infections/drug therapy , Acinetobacter Infections/microbiology , Adult , Anti-Bacterial Agents/therapeutic use , Child , Drug Resistance, Multiple, Bacterial , Female , Humans , Incidence , Male , Severity of Illness IndexABSTRACT
BACKGROUND: Long-term health care facilities have been recognized as reservoirs of multiresistant bacterial strains, especially methicillin-resistant Staphylococcus aureus (MRSA). Efforts to control MRSA in this setting usually have been only partially effective. We describe herein the eradication of epidemic MRSA from a Finnish health care center ward and affiliated nursing home. METHODS: The methods to control MRSA included (1) contact isolation precautions, (2) screening for asymptomatic carriage, (3) eradication of carriage, and (4) education of staff on hygienic measures. The first 6 patients with MRSA-positive findings were referred without delay to the Infectious Diseases Unit of the adjacent university hospital for eradication treatment. Later, an isolation unit of 6 rooms was founded in the health care center, where the MRSA-colonized patients were nursed as a separate cohort until they, in succession, were referred to the Infectious Diseases Unit for decolonization. RESULTS: From May 20 through August 17, 1993, the epidemic MRSA strain was isolated from 8 long-term patients on the 40-bed ward of the health care center, 4 of the 59 residents of the nursing home, and 1 member of the staff. Eradication of carriage was successful in all except 1 patient with dementia, who was nursed in contact isolation in the health care center until his death 21 months later. CONCLUSIONS: It is possible to eradicate MRSA from a long-term health care facility even after 13 cases by applying strict control measures. Our experience may be valuable in the future decision-making process for control of new and more challenging multiresistant bacteria, eg, vancomycin-resistant strains of MRSA.
Subject(s)
Homes for the Aged , Methicillin Resistance , Methicillin/therapeutic use , Nursing Homes , Staphylococcal Infections/drug therapy , Staphylococcus aureus/drug effects , Aged , Cohort Studies , Disease Outbreaks , Humans , Staphylococcal Infections/epidemiology , Staphylococcal Infections/prevention & controlABSTRACT
Parainfluenza virus type 3 (PIV3) is associated with a high mortality rate in BMT recipients with lower respiratory tract infections. We describe nine patients with hematological malignancies (five having undergone either allogeneic or autologous stem cell transplantation) identified as having PIV3 infection during a 2-month period in a Hematology Unit. Four patients with infiltrates on chest radiograph received intravenous ribavirin therapy; all survived. The infection was community-acquired in two patients, while nosocomial origin of the disease was evident, or presumed, in the remaining seven. The policy implemented to control the spread of PIV3 was as follows: (1) nasopharyngeal samples for antigen detection were obtained from all patients presenting with respiratory symptoms; (2) all diagnosed (or suspected) PIV3-positive hematological patients were nursed following contact isolation precautions, preferably in the Infectious Diseases Unit; and (3) staff were given further education on hospital hygiene. Our experience shows that it may be possible to avoid mortality for PIV3 lower respiratory tract infection in immunocompromised patients by early commencement of intravenous ribavirin. It is also possible, even without closing the ward, to contain nosocomial spread of PIV3 by implementing systematic nasopharyngeal sampling for rapid diagnostics, and by strict adherence to cohorting and contact isolation precautions.